Національний Медичний Університет Імені О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Імені О.О. БогомольцяfiledCriticalНаціональний Медичний Університет Імені О.О. Богомольця
Priority to UAU201509409UpriorityCriticalpatent/UA105586U/en
Publication of UA105586UpublicationCriticalpatent/UA105586U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for treating the hepatic encephalopathy involves the use of standard treatment. Additionally Choline alphoscerate (Gliatilin) is administered intravenously in a volume of 4 mL (one ampoule contains 1000 mg of Choline alphoscerate) daily, #10. Then the drug is taken in capsules at a daily dose of 800 mg for one month.
UAU201509409U2015-09-302015-09-30Method for treating hepatic encephalopathy
UA105586U
(en)